39 results on '"Tan, Wenliang"'
Search Results
2. FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma
3. CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA
4. Prognostic stratification based on HIF-1α signaling for evaluating hypoxia status and immune landscape in hepatocellular carcinoma
5. GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
6. CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway
7. Heating induced aggregation in non-fullerene organic solar cells towards high performance
8. Effect of loading pressure on mechanical properties and interface characteristics of 7056 Al alloy particle reinforced Zr-Al-Ni-Cu bulk metallic glass matrix composite prepared by spark plasma sintering
9. Protein PDK4 Interacts with HMGCS2 to Facilitate High Glucoseinduced Myocardial Injuries
10. Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis
11. SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway
12. Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
13. MicroRNA-22-3p Restrains the Proliferation, Phenotypic Transformation, and Migration of Vascular Smooth Muscle Cells by Manipulating TOMM40
14. Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study
15. Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]
16. Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
17. SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
18. High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma
19. Antihypertensive treatment and risk factors for syncope in asymptomatic aortic stenosis patients with hypertension
20. Revealing the Side‐Chain‐Dependent Ordering Transition of Highly Crystalline Double‐Cable Conjugated Polymers
21. Lactate is Associated with Increased 30-Day Mortality in Critically Ill Patients with Alcohol Use Disorder
22. miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
23. Erratum: TRAF4 Regulates Migration, Invasion, and Epithelial–Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma
24. Antihypertensive treatment and risk factors for syncope in asymptomatic aortic stenosis patients with hypertension.
25. Modulation of J-Aggregation of Nonfullerene Acceptors toward Near-Infrared Absorption and Enhanced Efficiency
26. Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma
27. Microstructure and Mechanical Properties of Zr–Al–Ni–Cu Metallic Glassy Particles Reinforced 7056 Al Alloy Matrix Composites Obtained by Spark Plasma Sintering
28. TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
29. miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression
30. Self-Assembled 2D Perovskite Layers for Efficient Printable Solar Cells
31. Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection
32. Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway
33. TRAF4 Regulates Migration, Invasion, and Epithelial‐Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma
34. An observational study of donafenib as adjuvant therapy to prevent hepatocellular carcinoma recurrence after curative surgery.
35. Real-world efficacy and safety of donafenib-based therapies in patients with unresectable hepatocellular carcinoma: A retrospective study.
36. Erratum.
37. Self‐Assembled 2D Perovskite Layers for Efficient Printable Solar Cells.
38. Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy.
39. In-Doped ZnO Electron Transport Layer for High-Efficiency Ultrathin Flexible Organic Solar Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.